InvestWiser
Getinge AB ser. B
GETI-B · Nasdaq Stockholm · Healthcare
246.40SEK
−0.3%last day
Price as of 2 October 2026
Performance
1 month
+0.9%
1 year
+24.7%
3 years, per year
+10.6%
5 years, per year
−4.6%
Largest fall, 3 years
−57.0%
Below the peak now
−36.6%
Volatility, 1 year
23.6%
Return with dividends reinvested.
Key figures
P/E
24.2
P/B
2.1
Dividend yield
1.9%
Return on equity
+8.6%
Net margin
+7.8%
Market value
6.7 bn USD
Quality, value and trend
Where Getinge stands against every Nordic stock today. 100 is best.
89
Profitability and a sound balance sheet over time. Better than 89% of Nordic stocks.
49
The price measured against earnings, assets and cash flow. Better than 49% of Nordic stocks.
91
The price development over the past year. Better than 91% of Nordic stocks.
94
Quality, value and trend together. Better than 94% of Nordic stocks.
About Getinge
Getinge AB ser. B is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 12,000 employees.
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions.
See the full analysis in InvestWiser.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
See the full analysis